# A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

> **NCT00296504** · PHASE3 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 753 (actual)

## Conditions studied

- Infection, Human Immunodeficiency Virus

## Interventions

- **DRUG:** fosamprenavir (GW433908)
- **DRUG:** ritonavir

## Key facts

- **NCT ID:** NCT00296504
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 753 (ACTUAL)
- **Last updated:** 2013-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296504, "A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00296504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*